Senior insider sale
Chief Scientific Officer at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$409.6K
28.56K shares
What this filing means
LORRAIN DANIEL S. plans to sell 28.56K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $409.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/11/2026ACC: 0001950047-26-001158
Officer· Chief Scientific Officer
Since Mar 2026
28.56K
Shares to sell
$409.6K
Approx. market value
16.05K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
2/11/2026
16.05KTotal acquired16.05K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/11/2026 | Exercise of Stock Options Cash | 16.05K | — |
| Total | 16.05K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.17K
Market value
$62.3K
2/3/2026
—Completed
Units to sell
4.17K
Market value
$43.5K
1/5/2026
—Completed
Units to sell
4.17K
Market value
$51.0K
12/23/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.05K
Market value
$252.8K
2/11/2026
Total
Units
28.56K
Value
$409.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/3/2026 | 4.17K | $62.3K | — | Completed |
1/5/2026 | 4.17K | $43.5K | — | Completed |
12/23/2025 | 4.17K | $51.0K | — | Completed |
| Planned — Approximate Date | ||||
2/11/2026 | 16.05K | $252.8K | NASDAQ | Planned |
| Total | 28.56K | $409.6K | ||